Latest Breaking News On - Cochicine cardiovascular outcomes trial - Page 1 : vimarsana.com

After a recent myocardial infarction, daily low-dose colchicine reduces the risk for cardiovascular events in patients with type 2 diabetes, a recent study shows.

University hospital of montpellierCochicine cardiovascular outcomes trialUniversity hospitalDiabetes mellitus type 2Iabetes mellitus type iiType 2 diabetesYpe 2 dmMyocardial infarctionIpid managementHemoglobin a1cHemoglobin a1c testGlycated hemoglobinGlycosylated hemoglobinIabetic control index1c assayVldl cholesterol